Gastrointestinal symptoms and complications in patients hospitalized due to COVID-19, an international multicentre prospective cohort study (TIVURON project)

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Díaz, 2020, Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: a large cohort from South America, Gastroenterology, 159, 1148, 10.1053/j.gastro.2020.05.014 Sultan, 2020, AGA Institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19, Gastroenterology, 159, 320, 10.1053/j.gastro.2020.05.001 Mao, 2020, Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 5, 667, 10.1016/S2468-1253(20)30126-6 Elmunzer, 2021, Digestive manifestations in patients hospitalized with coronavirus disease 2019, Clin Gastroenterol Hepatol, 19, 1355, 10.1016/j.cgh.2020.09.041 Dong, 2020, ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19, Biomed Pharmacother, 131, 110678, 10.1016/j.biopha.2020.110678 Wu, 2020, Prolonged presence of SARS-CoV-2 viral RNA in faecal samples, Lancet Gastroenterol Hepatol, 5, 434, 10.1016/S2468-1253(20)30083-2 Villapol, 2020, Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome, Transl Res, 226, 57, 10.1016/j.trsl.2020.08.004 Parohan, 2020, Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies, Hepatol Res, 50, 924, 10.1111/hepr.13510 Saviano, 2021, Liver disease and coronavirus disease 2019: from pathogenesis to clinical care, Hepatology, 74, 1088, 10.1002/hep.31684 Wang, 2020, Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia, Gastroenterology, 159, 367, 10.1053/j.gastro.2020.03.055 Taxonera, 2021, Can COVID-19 trigger de novo inflammatory bowel disease?, Gastroenterology, 160, 1029, 10.1053/j.gastro.2020.11.026 Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5 Kichloo, 2020, COVID-19 and hypercoagulability: a review, Clin Appl Thromb Hemost, 26, 10.1177/1076029620962853 González Lázaro, 2020, Ischemic colitis and short bowel disease due to coronavirus disease 2019 (COVID 19), Clin Nutr ESPEN, 40, 406, 10.1016/j.clnesp.2020.08.009 Bruni, 2020, Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis, World J Emerg Surg, 15, 43, 10.1186/s13017-020-00320-5 de-Madaria, 2021, COVID-19 and acute pancreatitis: examining the causality, Nat Rev Gastroenterol Hepatol, 18, 3, 10.1038/s41575-020-00389-y Spiegel, 2014, Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales, Am J Gastroenterol, 109, 1804, 10.1038/ajg.2014.237 Colmenero, 2021, Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients, J Hepatol, 74, 148, 10.1016/j.jhep.2020.07.040 Pan, 2020, Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicentre study, Am J Gastroenterol, 115, 766, 10.14309/ajg.0000000000000620 Tariq, 2020, Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis, Mayo Clin Proc, 95, 1632, 10.1016/j.mayocp.2020.06.003 Marasco, 2022, Prevalence of gastrointestinal symptoms in severe acute respiratory syndrome coronavirus 2 infection: results of the prospective controlled multinational GI-COVID-19 study, Am J Gastroenterol, 117, 147, 10.14309/ajg.0000000000001541 Chen, 2020, Are gastrointestinal symptoms specific for coronavirus 2019 infection? A prospective case–control study from the United States, Gastroenterology, 159, 10.1053/j.gastro.2020.05.036 Tarik, 2021, Gastrointestinal manifestations with COVID-19 virus infection: a Moroccan prospective study, Arab J Gastroenterol, 22, 305, 10.1016/j.ajg.2021.07.004 Shehab, 2021, Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis, BMJ Open Gastroenterol, 8, e000571, 10.1136/bmjgast-2020-000571 Inamdar, 2020, Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis, Gastroenterology, 159, 2226, 10.1053/j.gastro.2020.08.044 Calabrese, 2020, Onset of ulcerative colitis during SARS-CoV-2 infection, Dig Liver Dis, 52, 1228, 10.1016/j.dld.2020.06.003 Drake, 2021, Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study, Lancet, 398, 223, 10.1016/S0140-6736(21)00799-6 Sarin, 2020, Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection: the APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study), Hepatol Int, 14, 690, 10.1007/s12072-020-10072-8 Phipps, 2020, Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. Cohort, Hepatology, 72, 807, 10.1002/hep.31404 Kumar, 2020, Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: a systematic review and meta-analysis, Indian J Gastroenterol, 39, 268, 10.1007/s12664-020-01058-3 Weber, 2021, Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study, Gut, 70, 1925, 10.1136/gutjnl-2020-323800